Persistence of newer anti-obesity medications in a real-world setting

Evaluate real-world data on persistence with anti-obesity medications (AOMs) and explore associated patient factors. Truven Health MarketScan® data were analyzed to evaluate utilization of AOMs approved for long-term use between 4/2015 and 3/2016. Kaplan-Meier survival analyses were used to evaluate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes research and clinical practice 2018-09, Vol.143, p.348-356
Hauptverfasser:	Ganguly, Rahul, Tian, Ye, Kong, Sheldon X., Hersloev, Malene, Hobbs, Todd, Smolarz, B. Gabriel, Ramasamy, Abhilasha, Haase, Christiane Lundegaard, Weng, Wayne
Format:	Artikel
Sprache:	eng
Schlagworte:	Adherence Anti-obesity medications AOM Liraglutide Long-term Obesity Persistence Pharmacotherapy Real-world Retrospective
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!